Navigation Links
China Medicine Announces Conference Call to Discuss First Quarter 2010 Results
Date:5/10/2010

GUANGZHOU, China, May 10 /PRNewswire-Asia/ -- China Medicine Corporation (OTC Bulletin Board: CHME) is a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicine products, other nutraceuticals, medical devices, and medical formulations, today announced that it will conduct a conference call at 9:00 a.m. Eastern Time on Thursday, May 13, 2010 to discuss its first quarter 2010 results.

Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of China Medicine Corporation, will be Mr. Fred Cheung, Chief Financial Officer. The Company plans to issues its earnings release prior to the call.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 1-800-688-0796. International callers should dial 1-617-614-4070, Conference Passcode: 10924041.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, May 13, at 11:00 p.m. Eastern Time. To access the replay, dial 1-888-286-8010, international callers dial 1-617-801-6888, and enter the passcode of 97174060.

About China Medicine Corporation

China Medicine Corporation, a comprehensive enterprise with a research and development centre, manufacturing facilities and well established sales network, engages in the production and distribution of prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company distributes its products to wholesale distributors, including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company is developing a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds.

    For more information, please contact:

    Company Contact:
     Gavin Chen
     Assistant to CFO
     China Medicine Corporation
     Tel:   +86-20-8737-2102
     Email: konzern08@163.com

    Investor Relations Contact:
     Ms. Lei Huang, Account Manager
     CCG Investor Relations
     Tel:   +1-646-833-3417 (NY Office)
     Email: lei.huang@ccgir.com
     Web:   http://www.ccgirasia.com

     Mr. Crocker Coulson, President
     CCG Investor Relations
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com


'/>"/>
SOURCE China Medicine Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Sky One Medical Announces Conference Call to Discuss First Quarter 2010 Results
2. Reportlinker Adds Future of Red Biotechnology in China
3. Chinas first open-access journal Nano Research listed in Science Citation Index
4. Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study
5. China Cord Blood Corporation Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2010
6. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
7. China Sky One Medical to Attend Rodman & Renshaw Annual China Investment Conference
8. China Baicaotang to Attend Rodman & Renshaw Annual China Investment Conference
9. China Medical Technologies Reports Third Fiscal Quarter Financial Results
10. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
11. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) ... million US Dollar project, for the , Supply ... Enrolment, and IT Infrastructure , to ... implementation of Identity Management Solutions. Numerous renowned international vendors participated ... was selected for the most compliant and innovative ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):